Women's Health Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New breast cancer findings from University of Medicine and Dentistry of New Jersey described
July 19th, 2009
"This study was undertaken to evaluate the prognostic significance of Bcl-2, a apoptosis-related protein, in patients with early stage breast cancer treated with breast conservation treatment (BCT). After obtaining IRB approval, 504 patients with early stage breast cancer treated with BCT were entered in this study," scientists in the United States report. "The paraffin specimens were constructed into tissue micro-arrays with two-fold redundancy, processed and stained for Bcl-2 antibody. Bcl-2 expression was correlated with other clinicopathological parameters and clinical outcomes. Bcl-2 expression was identified in 116 cases (28%). Bcl-2 expression was positively...
Source: Women's Health Law Weekly (2009-07-19)
|
